FDA Adverse Event Malfunction Summary report: N

BD SUREPREP¿ CAPILLARY TUBES- PLAIN

MDR report key: 14458891 · Received May 20, 2022

Report

Report Number
1119779-2022-00726
Event Type
Malfunction
Date Received
May 20, 2022
Date of Event
March 1, 2022
Report Date
August 30, 2022
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
GIO
UDI-DI
30382904203154
PMA / PMN Number
K884623
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IN THIS MDR, BECTON, DICKINSON & CO. IN (B)(4) HAS BEEN LISTED AS SAFE-TEC CLINICAL PRODUCTS LLC IS AN OEM MANUFACTURING SITE. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION: B.5. ADDITIONAL INFORMATION INDICATES THAT THE EVENT OCCURRED 3 TIMES.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY THE CUSTOMER COMPLAINT ON PRODUCT 420315, LOT 110521, WAS NOT CONFIRMED. THE CUSTOMER REPORTED THAT THEIR PLAIN SUREPREP CAPILLARY TUBES (CAT. 420315, LOT 110521) HAD A 20-50% LEAKAGE ON CENTRIFUGATION FROM THE ¿SEALED¿ END OF THE CAPILLARY TUBE. AN INVESTIGATION OF THE RETAIN SAMPLES AND THE DEVICE HISTORY RECORD DID NOT SHOW ANY DEFECTS. A REVIEW OF THE RETURNED SAMPLES REVEALED NO DEFECTS. A REVIEW OF PAST COMPLAINTS FOR THIS PRODUCT DOES NOT INDICATE A TREND FOR THIS ISSUE. NO FURTHER ACTION WILL BE TAKEN AS THIS IS AN ISOLATED INCIDENT. BD QUALITY ASSURANCE WILL CONTINUE TO MONITOR FOR TRENDING. H3 OTHER TEXT : SEE H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD SUREPREP¿ CAPILLARY TUBES- PLAIN THE CUSTOMER OBSERVED LEAKAGE FROM TUBES AFTER CENTRIFUGATION. THIS EVENT OCCURRED 1 TIME(S). THERE IS NO INDICATION THAT FALSE RESULTS WERE REPORTED TO HEALTH CARE PRACTITIONERS. THERE IS NO INDICATION OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS 20-50% LEAKAGE ON CENTRIFUGATION FROM THE ¿SEALED¿ END OF THE CAPILLARY TUBE."

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD SUREPREP¿ CAPILLARY TUBES- PLAIN THE CUSTOMER OBSERVED LEAKAGE FROM TUBES AFTER CENTRIFUGATION. THIS EVENT OCCURRED 3 TIME(S). THERE IS NO INDICATION THAT FALSE RESULTS WERE REPORTED TO HEALTH CARE PRACTITIONERS. THERE IS NO INDICATION OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS 20-50% LEAKAGE ON CENTRIFUGATION FROM THE ¿SEALED¿ END OF THE CAPILLARY TUBE." "DID THEY TRY USING A DIFFERENT CENTRIFUGE AND DID IT WORK? YES. SAME ISSUES 2 OTHER CENTRIFUGES. "

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD SUREPREP¿ CAPILLARY TUBES- PLAIN THE CUSTOMER OBSERVED LEAKAGE FROM TUBES AFTER CENTRIFUGATION. THIS EVENT OCCURRED 3 TIME(S). THERE IS NO INDICATION THAT FALSE RESULTS WERE REPORTED TO HEALTH CARE PRACTITIONERS. THERE IS NO INDICATION OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS 20-50% LEAKAGE ON CENTRIFUGATION FROM THE ¿SEALED¿ END OF THE CAPILLARY TUBE." "DID THEY TRY USING A DIFFERENT CENTRIFUGE AND DID IT WORK? YES. SAME ISSUES 2 OTHER CENTRIFUGES. "

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
518475 BD SUREPREP¿ CAPILLARY TUBES- PLAIN TUBE, COLLECTION, CAPILLARY BLOOD GIO BECTON, DICKINSON & CO. (SPARKS) 420315 110521 30382904203154

Patients

Seq Age Sex Outcome Treatment
1 Unknown